TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Salipro Biotech AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
4,009
|
4,990
|
3,279 |
| Financial expenses |
1
|
0
|
0 |
| Earnings before taxes |
-2,864
|
-1,608
|
-1,411 |
| EBITDA |
-2,491
|
-1,234
|
-1,064 |
| Total assets |
10,492
|
13,114
|
15,973 |
| Current assets |
6,411
|
9,536
|
12,405 |
| Current liabilities |
1,164
|
985
|
1,025 |
| Equity capital |
9,328
|
12,129
|
14,948 |
| - share capital |
46
|
46
|
50 |
| Employees (average) |
9
|
7
|
6 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
88.9%
|
92.5%
|
93.6% |
| Turnover per employee |
445
|
713
|
546 |
| Profit as a percentage of turnover |
-71.4%
|
-32.2%
|
-43.0% |
| Return on assets (ROA) |
-27.3%
|
-12.3%
|
-8.8% |
| Current ratio |
550.8%
|
968.1%
|
1210.2% |
| Return on equity (ROE) |
-30.7%
|
-13.3%
|
-9.4% |
| Change turnover |
-1,008
|
1,977
|
708 |
| Change turnover % |
-20%
|
66%
|
28% |
| Chg. No. of employees |
2
|
1
|
0 |
| Chg. No. of employees % |
29%
|
17%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.